Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v11-EN
Language English English
Date Updated 2017-08-19 2017-08-07
Drug Identification Number 02256487 02256487
Brand name VFEND FOR INJECTION VFEND FOR INJECTION
Common or Proper name VFEND VFEND
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients VORICONAZOLE VORICONAZOLE
Strength(s) 200MG 200MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size each each
ATC code J02AC J02AC
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-05-31 2017-05-31
Actual start date
Estimated end date 2017-08-18 2017-08-11
Actual end date 2017-08-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Released August 18, 2017. Inventory is currently available through the CPDN network and projected to cover demand to early June. Inventory is currently available through the CPDN network and projected to cover demand to early June.
Health Canada comments